A new type of peptide receptor radionuclide therapy (PRRT) appears to be safe for patients with metastatic neuroendocrine tumors who…

New Alzheimer’s drugs have shown promise, but are not very effective, and ARIA’s safety risks, high costs, and regulatory disagreements…

A first-in-class PET imaging approach can accurately detect biomarkers for chronic traumatic encephalopathy (CTE), a severe neurodegenerative disease associated with…

When political news articles contradict what readers expect from a particular media outlet, they tend to think more deeply about…

Scott Morgan/ASCO Adam Feuerstein is a senior writer and biotechnology columnist, reporting on the intersection of drug development, business, Wall…